UCI-Led Study Reveals How SARS Coronavirus Hijacks Host Cells

Article

UC Irvine infectious disease researchers have uncovered components of the SARS coronavirus which triggered a major outbreak of severe acute respiratory syndrome in 2002-03 that allow it to take over host cells in order to replicate.

This insight is critical for a full understanding of any outbreaks caused by such viruses and may prove beneficial in the development of therapies not only for human coronavirus infections but for other pathogenic illnesses as well. Study results appear online in the July/August issue of mBio.

Megan Angelini, a graduate student in professor Michael Buchmeiers laboratory in the Department of Molecular Biology & Biochemistry at UC Irvine, and colleagues found that three proteins in the SARS coronavirus nsp3, nsp4 and nsp6 have the ability to hijack a host cells internal membranes and utilize them to make more virus.

Understanding how the virus uses the host cell to reproduce itself could lead to potential therapies for these kinds of pathogens, says Buchmeier, who is also deputy director of the Pacific Southwest Regional Center of Excellence for Biodefense & Emerging Infectious Diseases at UC Irvine.

Additionally, he said, since membrane rearrangement is a tactic employed by all known positive-sense, single-stranded RNA viruses, including those responsible for polio and dengue fever, this work adds to that body of knowledge.

Although the majority of infections caused by coronaviruses in humans are relatively mild, the SARS outbreak of 2002 and 2003 and the emergence last fall of the Middle East respiratory syndrome coronavirus highlight their ability to potentially infect millions around the globe.

Benjamin Neuman of Englands University of Reading and Marzieh Akhlaghpour 11 also contributed to the study, which was supported by the National Institutes of Health (grants 5T32AI007319-23 and AI059799) and the California Center for Antiviral Drug Discovery (MRPI grant 143226).

Source:  UC Irvine

Related Videos
Jill Holdsworth, MS, CIC, FAPIC, CRCST, NREMT, CHL
Jill Holdsworth, MS, CIC, FAPIC, CRCSR, NREMT, CHL, and Katie Belski, BSHCA, CRCST, CHL, CIS
Baby visiting a pediatric facility  (Adobe Stock 448959249 by Rawpixel.com)
Antimicrobial Resistance (Adobe Stock unknown)
Anne Meneghetti, MD, speaking with Infection Control Today
Patient Safety: Infection Control Today's Trending Topic for March
Infection Control Today® (ICT®) talks with John Kimsey, vice president of processing optimization and customer success for Steris.
Picture at AORN’s International Surgical Conference & Expo 2024
Infection Control Today and Contagion are collaborating for Rare Disease Month.
Related Content